Clinical and Molecular Epidemiology of Cancer

Research group

Group Leader

Miquel Porta Serra

Cancer is a complex set of processes that result from the interaction of genetic, clinical and environmental factors, “environmental” including the physical environment, as well as the public health, cultural, economical and political environments. Thus, integrative studies on the causes of cancer are a natural meeting point between molecular biology and epidemiology. Our aim is to achieve an optimal integration of professional cultures, scientific knowledge, methodologies and techniques from public health, clinical medicine and the biological sciences. We are a team that has worked across disciplines for more than two decades, one of the pioneer groups in Spain on clinical and molecular epidemiology.

Members

Immaculada Collet Diví (Technician)

Magda Gasull Panadès (Technician)

Natàlia Pallarès Fontanet (Technician)

José Antonio Rodríguez Pumarega (Technician)

Yolanda Rovira Pons (Research Assistant)

 

more info

Main Publications

• Lope V, García-Esquinas E, Pérez-Gómez B, Altzibar JM (…), Pumarega JA, Dierssen-Sotos T, Barrio-Lera JP (…), Kogevinas M, Aragonés N, Castaño-Vinyals G, Pollán M. Perinatal and childhood factors and risk of breast cancer subtypes in adulthood. Cancer Epidemiol 2016; 40: 22-30. IF 2.644. Q1.

• NCD Risk Factor Collaboration (NCD-RisC). Bentham J, Di Cesare M, Stevens GA, Zhou B, Bixby H, Cowan M, (…), Gasull M, Porta M (…),  Paciorek CJ, Riboli E, Ezzati M. A century of trends in adult human height. eLife 2016; 5: e13410. IF 8.303. Q1.

• NCD Risk Factor Collaboration (NCD-RisC). Di Cesare M, Bentham J, Stevens GA, Zhou B, Danaei G, Lu Y, (…),  Gasull M, Porta M (…),  Miranda JJ, Mostafa A, Turley ML, Paciorek CJ, Gunter M, Ezzati M. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. The Lancet 2016; 387: 1377–1396. IF 44.002. Q1.

• NCD Risk Factor Collaboration (NCD-RisC).  Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, (…), Gasull M, Porta M (…),  Pilav A, Ramachandran A, Romdhane HB, Paciorek CJ, Bennett JE, Ezzati M. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. The Lancet 2016; 387:1513–1530. IF 44.002. Q1.

• Porta M, Bolúmar F. Caution: work in progress : While the methodological "revolution" deserves in-depth study, clinical researchers and senior epidemiologists should not be disenfranchised. Eur J Epidemiol 2016; 31(6): 535-539. IF 7.105. Q1.

• Pumarega JA, Gasull M, Lee DH, López T, Porta M. Number of Persistent Organic Pollutants Detected at High Concentrations in Blood Samples of the United States Population. PLoS ONE 2016; 11(8): e0160432. IF 3.057. Q1.

• Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J (...), Porta M, Quiros JR, Riboli E (...), Stolzenberg-Solomon RS, Wolpin BM, Kraft P, Klein AP, Canzian F, Amundadottir LT. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget 2016; 7(41): 66328-66343. IF 5.008. Q1.

Ongoing Research Projects

• Plasma concentrations of organochlorine compounds and lifestyle factors pancreatic cancer risk within the EPIC cohort

− Fundació La Marató de TV3 (20132910)

− From 2014 to 2017

− Principal investigator: Porta Serra, Miquel

 

• Concentraciones sanguíneas de compuestos organoclorados, estilo de vida y riesgo de cáncer de páncreas en la cohorte EPIC

− Fondo de Investigación Sanitaria. ISCIII (PI13/00020)

− From 2014 to 2017

− Principal investigator: Porta Serra, Miquel

Participation in Research Networks

• CIBERESP: Epidemiología y salud pública

− Fondo de Investigación Sanitaria. ISCIII (CB06/02/0034)

− Principal investigator: Porta Serra, Miquel

Group’s Recognitions

• Officially recognised as a consolidated research group by the Generalitat de Catalunya: Epidemiologia Clínica i Molecular del Càncer (2014-2017)

− Agència de Gestió d’Ajuts Universitaris i de Recerca (SGR 1012)

− Principal investigator: Porta Serra, Miquel

C/ Doctor Aiguader, 88

08003 Barcelona

(+34) 93 316 04 00

info@imim.es